Adjuvant oral 5-fluorouracil for cervical cancer: Japanese Gynecologic Oncology Group report.

Abstract

Japanese women with low-stage cervical cancer receiving radical hysterectomy and radiotherapy have a good 5-year survival rate. However, women with risk factors such as nodal metastasis may benefit from adjuvant chemotherapy, which was studied in women having surgery alone or surgery plus radiotherapy. Patients having surgery alone (S) (n=623) or surgery… (More)

Topics

Cite this paper

@article{Yamamoto2004AdjuvantO5, title={Adjuvant oral 5-fluorouracil for cervical cancer: Japanese Gynecologic Oncology Group report.}, author={Kaichiro Yamamoto and Rikuichi Izumi and Kazuo Hasegawa and Hisayoshi Nakajima and Kazutomo Ohashi and Ryuichi Kudo and Hiroyuki Okuda and Takeshi Takahashi and Hideki Origasa and Hajime Sugimori}, journal={International journal of oncology}, year={2004}, volume={24 5}, pages={1175-9} }